479090-38-5 Usage
Uses
Used in Pharmaceutical Research:
4-Bromothiophen-2-ylmethylamine is used as a building block for the synthesis of various bioactive molecules, contributing to the development of new drugs and therapeutic agents. Its presence of both amine and thiol functionalities allows for a wide range of chemical reactions and modifications, making it a valuable component in the creation of diverse pharmaceutical compounds.
Used in Organic Synthesis:
4-Bromothiophen-2-ylmethylamine is used as a versatile reagent in organic synthesis, particularly for the preparation of organobromides and organosulfur compounds. Its unique structure and functional groups enable chemists to explore various synthetic pathways and create a range of complex molecules with potential applications in different industries.
Used in Chemical Research:
4-Bromothiophen-2-ylmethylamine is employed as a research tool in chemical studies, allowing scientists to investigate its properties, reactivity, and potential applications. Its presence in the field of chemical research helps to expand the understanding of organobromides and organosulfur compounds, as well as their interactions with other chemical entities.
Check Digit Verification of cas no
The CAS Registry Mumber 479090-38-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,7,9,0,9 and 0 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 479090-38:
(8*4)+(7*7)+(6*9)+(5*0)+(4*9)+(3*0)+(2*3)+(1*8)=185
185 % 10 = 5
So 479090-38-5 is a valid CAS Registry Number.
InChI:InChI=1/C5H6BrNS.ClH/c6-4-1-5(2-7)8-3-4;/h1,3H,2,7H2;1H
479090-38-5Relevant academic research and scientific papers
Antibacterial agents
-
, (2008/06/13)
The present invention provides compounds of formula (I): wherein R1-R6 and J and K have any of the values defined in the specification, and pharmaceutically acceptable salt thereof, that are useful as antibacterial agents. Also disclosed are pharmaceutical compositions comprising one or more compounds of formula I, processes for preparing compounds of formula I, and intermediates useful for preparing compounds of formula I.
